Robertson Jenny
Chief Legal Officer
Robertson Jenny has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Nov 20, 2025.
On the most recent filing, Robertson Jenny is listed as Chief Legal Officer at Lexeo Therapeutics, Inc. Inside the rolling window, Robertson Jenny reported no open-market purchases and 2 open-market sales totaling $37K in LXEO. The largest disclosed transaction in the window is a sale of 3,526 LXEO shares on Oct 17, 2025, worth $32K.
Companies traded
Other insiders at LXEO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$37K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Robertson Jenny made?
Robertson Jenny has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Robertson Jenny trade?
Robertson Jenny has filed SEC Form 4 disclosures for 1 company, including LXEO.
When was Robertson Jenny's most recent SEC Form 4 filing?
Robertson Jenny's most recent SEC Form 4 filing on Tracefour is dated Nov 20, 2025.
What is Robertson Jenny's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Robertson Jenny is listed as Chief Legal Officer.
What is Robertson Jenny's total buy and sell value in the current window?
Inside the rolling retention window, Robertson Jenny bought $0 and sold $37K based on SEC Form 4 filings.
What was Robertson Jenny's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,526 LXEO shares on 2025-10-17, worth $32K, per SEC Form 4 filings.